Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Comparison of the Pathological Complete Response Rate and Survival between HER2-low and HER2-zero Breast Cancer in Neoadjuvant Chemotherapy Setting: a Systematic Review and Meta-analysis

Article in Clinical Breast Cancer (May 2024)

Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Preprint in Research Square (March 2024)

HER2-low Breast Cancer: Now and in the Future

Article in Cancer Research and Treatment (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.